Full Length Research Paper
References
|
Aggoune N, Tali-Maamar H, Assaous F, Guettou B, Laliam R, Benamrouche N, Zerouki A, Naim M, Rahal K (2018). Wide spread of OXA-48-producing Enterobacteriaceae in Algerian hospitals: A four years' study. The Journal of Infection in Developing Countries 12(11):1039-1044. |
|
|
Breijyeh Z, Jubeh B, Karaman R (2020). Resistance of Gram-Negative Bacteria to Current Antibacterial Agents and Approaches to Resolve It. Molecules 25(6):1340. |
|
|
Dikoumba AC, Onanga R, Jean-Pierre H, Didelot MN, Dumont Y, Ouedraogo AS, Ngoungou EB, Godreuil S (2023). Prevalence and Phenotypic and Molecular Characterization of Carbapenemase-Producing Gram-Negative Bacteria in Gabon. The American Journal of Tropical Medicine and Hygiene 108(2):268-274. |
|
|
Dortet L, Cuzon G, Ponties V, Nordmann P (2017). Trends in carbapenemase-producing Enterobacteriaceae, France, 2012 to 2014. Eurosurveillance journal 22(6):30461. |
|
|
Elbadawi HS, Elhag KM, Mahgoub E, Altayb HN, Ntoumi F, Elton L, McHugh TD, Tembo J, Ippolito G, Osman AY, Zumla A, Abdel Hamid MM (2021). Detection and characterization of carbapenem resistant Gram?negative bacilli isolates recovered from hospitalized patients at Soba University Hospital, Sudan. BMC Microbiology 21:136. |
|
|
Gaibani P, Giani T, Bovo F, Lombardo D, Amadesi S, Lazzarotto T, Coppi M, Rossolini GM, Ambretti S (2022). Resistance to Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam in Gram-Negative MDR Bacilli: Molecular Mechanisms and Susceptibility Testing. Antibiotics 11(5):628. |
|
|
Haji SH, Aka STH, Ali FA (2021). Prevalence and characterisation of carbapenemase encoding genes in multidrugresistant Gram-negative bacilli. PLoS One 16(11):e0259005. |
|
|
Kim SH, Kim GR, Jeong J, Kim S, Shin JH (2020). Prevalence and characteristics of Carbapenemase-Producing Enterobacteriaceae in three tertiary-care Korean university hospitals between 2017 and 2018. Japanese Journal of Infectious Diseases. 73(6):431-436. |
|
|
López-Hernández I, Delgado-Valverde M, Fernández-Cuenca F, López-Cerero L, Machuca J, Pascual Á (2020). Carbapenemase-Producing Gram-Negative Bacteria in Andalusia, Spain, 2014-2018. Emerging Infectious Diseases 26(9):2218-2222. |
|
|
Lutgring JD (2019). Carbapenem-resistant Enterobacteriaceae: An emerging bacterial threat. Seminars in Diagnostic Pathology 36:182-186. |
|
|
Maamar B, Messadi AA, Thabet L (2019). Molecular profil and antibiotic resistance of carbapenemase-producing Enterobacteriaceae in burn patients. Annals of Burns and Fire Disasters 32(3):203-209. |
|
|
Mahamat OO, Lounnas M, Hide M, Tidjani A, Benavides J, Diack A, Somasse C, Gamougam K, Carrière C, Dominique D, Bañuls AL, Jean-Pierre H, Dumont Y, Compain F, Godreuil S (2019). Spread of NDM-5 and OXA-181 carbapenemase-producing Escherichia coli in Chad. Antimicrobial agents and chemotherapy 63(11):e00646-19. |
|
|
Manenzhe RI, Zar HJ, Nicol MP, Kaba M (2015). The spread of carbapenemase-producing bacteria in Africa: a systematic review. Journal of Antimicrobial Chemotherapy 70(1):23-40. |
|
|
Mushi MF, Mshana SE, Imirzalioglu C, Bwanga F (2014). Carbapenemase Genes among Multidrug Resistant Gram-Negative Clinical Isolates from a Tertiary Hospital in Mwanza, Tanzania. BioMed Research International 2014:303104. |
|
|
Nordmann P, Poirel L (2022). Resistance to carbapenems: from diagnosis to epidemic management. Available at: |
|
|
Okoche D, Asiimwe BB, Katabazi FA, Kato L, Najjuka CF (2015). Prevalence and Characterization of Carbapenem-Resistant Enterobacteriaceae Isolated from Mulago National Referral Hospital, Uganda. Plos One 10(8):e0135745. |
|
|
Poirel L, Walsh TR, Cuvillier V, Nordmann P (2011). Multiplex PCR for detection of acquired carbapenemase genes. Diagnostic Microbiology and Infectious Disease 70(1):119-123. |
|
|
Sader HS, Castanheira M, Flamm RK, Mendes RE, Farrell DJ, Jones RN (2015). Tigecycline activity tested against carbapenem- resistant Enterobacteriaceae from 18 European nations: results from the SENTRY surveillance program (2010-2013). Diagnostic Microbiology and Infectious Disease 83(2):183-186. |
|
|
Sanou S, Ouedraogo AS, Aberkane S, Vendrell J, Ouchar O, Bouzimbi N, Hema A, Poda A, Zoungrana J, Ouedraogo GA, Carrière C, Jean-Pierre H, Ouedraogo-Traore R, Godreuil S (2020). Prevalence and molecular characterization of extended spectrum β-lactamase, plasmid-mediated quinolone resistance, and carbapenemase-producing Gram-negative bacilli in Burkina Faso. Microbial Drug Resistance 27:18-24. |
|
|
Sekyere JO, Govinden U, Essack S (2016). The Molecular Epidemiology and Genetic Environment of Carbapenemases Detected in Africa. Microbial drug resistance 22(1):59-68. |
|
|
Yusuf I, Arzai AH, Haruna M, Sharif AA, Getso MI (2014). Detection of multi drug resistant bacteria in major hospitals in Kano, North-West, Nigeria. Brazilian Journal of Microbiology 45(3):791-798. |
|
Copyright © 2025 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
